← Leaderboards
Francine R. Kaufman
University Of Southern California
$3,074,581
Attributed
$3,074,581
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $916.4K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$3,074,581 · 11
By mechanism
U01$2,537,048 · 1
M01$537,533 · 10
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Carol A Miller$6,776,399
- Norman Arnheim$8,870,712
- Joanne L Zahorsky-Reeves$339,685
- Alan S. Wayne$836,852
- Anne L Peters$10,753,617
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectInsulinInsulin Dependent Diabetes MellitusDisease /Disorder Prevention /ControlDiabetes Mellitus TherapyPediatricsHuman Therapy EvaluationPancreatic IsletsDiabetes MellitusClinical TrialsFundingDiabetes Mellitus GeneticsUnited States National Institutes Of HealthResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseResourcesInstitutionGrantSourceEnzyme Linked Immunosorbent AssayBehavioral /Social Science Research TagFunctional AbilityImmunotherapy
Grant awards (25)
CLINICAL TRIAL: ANTITHYMOCYTE GLOBULIN ON PRESERVING BETA CELL FUNCTION IN NEW O$19,712
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1$15,072
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: EFFECTS OF ABATACEPT ON THE PROGRESSION OF TYPE 1 DIABATES IN NE$1,158
M01 · FY2009 · RR · contact PI
NEW ONSET OF TYPE 1 DIABETES MYCOPHENOLATE MOFETIL-DACLIZUMAB$1,158
M01 · FY2009 · RR · contact PI
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$38,457
M01 · FY2008 · RR · contact PI
Immunotherapy for Type 1 Diabetes$885,432
U01 · FY2007 · DK · contact PI
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$31,013
M01 · FY2007 · RR · contact PI
IMPROVING METABOLIC ASSESSMENTS IN TYPE 1 DIABETES MELLITUS CLINICAL TRIALS$10,886
M01 · FY2006 · RR · contact PI
Immunotherapy for Type 1 Diabetes$1
U01 · FY2006 · DK · contact PI
Proposal as a Clinical Center for Treatment$316,628
U01 · FY2005 · DK
Proposal as a Clinical Center for Treatment$329,477
U01 · FY2004 · DK
The Diabetes Prevention Trial-Type 1/Type 1 diabetes Trial Net$37,443
M01 · FY2004 · RR
Proposal as a Clinical Center for Treatment$313,982
U01 · FY2003 · DK
Proposal as a Clinical Center for Treatment$407,034
U01 · FY2002 · DK
NEUROCOGNITIVE FUNCTION OF CHILDREN DIAGNOSED WITH DIABETES BEFORE AGE 10$0
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL OF TYPE 1 DIABETES$0
M01 · FY2002 · RR
Immunotherapy for Type 1 Diabetes$284,494
U01 · FY2001 · DK
DIABETES PREVENTION TRIAL OF TYPE 1 DIABETES$155,764
M01 · FY2001 · RR
NEUROCOGNITIVE FUNCTION OF CHILDREN DIAGNOSED WITH DIABETES BEFORE AGE 10$155,764
M01 · FY2001 · RR
NEUROCOGNITIVE FUNCTION OF CHILDREN DIAGNOSED WITH DIABETES BEFORE AGE 10$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL OF TYPE 1 DIABETES$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL OF TYPE 1 DIABETES$35,553
M01 · FY2000 · RR
NEUROCOGNITIVE FUNCTION OF CHILDREN DIAGNOSED WITH DIABETES BEFORE AGE 10$35,553
M01 · FY2000 · RR
NEUROCOGNITIVE FUNCTION OF CHILDREN DIAGNOSED WITH DIABETES BEFORE AGE 10$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL OF TYPE 1 DIABETES$0
M01 · FY2000 · RR